Literature DB >> 32070661

Preemptive use of oral nonsteroidal anti-inflammatory drugs for the relief of inflammatory events after surgical removal of lower third molars: A systematic review with meta-analysis of placebo-controlled randomized clinical trials.

Edson Luiz Cetira Filho1, Francisco Samuel Rodrigues Carvalho2, Paulo Goberlânio de Barros Silva3, Daniel Almeida Ferreira Barbosa4, Karuza Maria Alves Pereira1, Thyciana Rodrigues Ribeiro5, Fábio Wildson Gurgel Costa6.   

Abstract

PURPOSE: To investigate the effectiveness of preemptive analgesia with nonsteroidal anti-inflammatory drugs (NSAIDs) for the relief of inflammatory events (pain, edema, and trismus) after surgical removal of third molars.
MATERIALS AND METHODS: A two-phase PROSPERO-registered systematic review was conducted in accordance with the PRISMA statement. PubMed, Scopus, Web of Science, COCHRANE, LILACS, DOSS, and gray literature were searched using the following terms (MeSH) or their combinations: molar, third; anti-inflammatory agents, non-steroidal; analgesia; preoperative period; pain management.
RESULTS: From a total of 2903 articles, 31 (n = 2184 subjects) were selected. All studies presented a low risk of bias but exhibited high heterogeneity in methodology. Ten studies were selected for the meta-analysis. Preemptive analgesia for removal of third molars reduced average pain scores, especially those 1 h and 6 h after surgery (n = 151, p < 0.001, 95% CI = -2.81 to -0.97), reduced the average consumption of medication, and decreased the number of patients requiring medication without affecting the average time for its first consumption.
CONCLUSION: In summary, most NSAIDs showed good results for inflammatory events and reduced average pain scores and consumption of rescue medication. However, more homogeneous and well-delineated clinical studies are necessary to determine a possible association between NSAIDs and the relief of inflammatory events.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  Analgesia; Nonsteroidal anti-inflammatory drugs; Pain management; Preoperative period; Third molar

Mesh:

Substances:

Year:  2020        PMID: 32070661     DOI: 10.1016/j.jcms.2020.01.016

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN: 1010-5182            Impact factor:   2.078


  5 in total

1.  Photobiomodulation therapy reduces postoperative pain after third molar extractions: A randomized clinical trial.

Authors:  C Isolan; M-D Kinalski; O-A Leão; L-K Post; T-M Isolan; M-B Dos Santos
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2021-05-01

Review 2.  Analgesics for Dental Implants: A Systematic Review.

Authors:  Matteo Melini; Andrea Forni; Francesco Cavallin; Matteo Parotto; Gastone Zanette
Journal:  Front Pharmacol       Date:  2021-01-27       Impact factor: 5.810

Review 3.  Pre-emptive analgesic efficacy of injected ketorolac in comparison to other agents for third molar surgical removal: a systematic review.

Authors:  Sunnypriyatham Tirupathi; Srinitya Rajasekhar; Sardhar Singh Maloth; Aishwarya Arya; Pushpalatha Tummalakomma; Rama Brahman Lanke
Journal:  J Dent Anesth Pain Med       Date:  2021-01-29

4.  The Use of Cryotherapy in Conjunction with Surgical Removal of Mandibular Third Molars: a Single-Blinded Randomized Controlled Trial.

Authors:  Marie Kjærgaard Larsen; Thomas Kofod; Thomas Starch-Jensen
Journal:  J Oral Maxillofac Res       Date:  2021-12-31

5.  Effect of preemptive photobiomodulation associated with nimesulide on the postsurgical outcomes, oxidative stress, and quality of life after third molar surgery: a randomized, split-mouth, controlled clinical trial.

Authors:  Edson Luiz Cetira Filho; Paulo Goberlânio Barros Silva; Deysi Viviana Tenazoa Wong; Celia Choquenaira-Quispe; Francisco Rafael Alves Santana Cesário; Gisele de Sousa Nogueira; Alan Vieira Costa de Sousa; Andréa Silvia Walter de Aguiar; Said Goncalves da Cruz Fonseca; Fabio Wildson Gurgel Costa
Journal:  Clin Oral Investig       Date:  2022-08-11       Impact factor: 3.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.